-
Recent studies have shown that acupuncture can help control several symptoms and side effects such as pain, fatigue, dry mouth, nausea, and vomiting associated with a variety of cancers and their treatments.
-
New research shows that despite nearly three decades of safe sex and clean needle messages and HIV prevention work, a large proportion of people at risk for HIV infection continue to engage in high-risk behaviors.
-
A new model HIV/AIDS prevention program uses a group skills-building and peer-group led model to build on HIV clinicians' risk reduction messages to disadvantaged women who are HIV positive.
-
AIDS Alert asked Mark Ishaug, president and chief executive officer of the newly-formed AIDS United of Washington, DC, to discuss why the National AIDS Fund and the national policy advocacy group AIDS Action merged and what this will mean for people living with HIV/AIDS and the clinicians providing their care. His answers are presented below in a question-and-answer (Q&A) format.
-
On Dec. 22, 2010, the Food and Drug Administration approved a new 200 mg etravirine (Intelence®) tablet. Etravirine was originally approved in 2008, in only a 100 mg tablet formulation. The new 200 mg dosage form can help reduce pill burden for patients taking Intelence.
-
The National Newspaper Publishers Association (NNPA) has joined a cooperative effort using enhanced media coverage to re-engage African Americans in the fight against HIV/AIDS.
-
-
In this study, 2,499 hiv-seronegative men or transgender females who have sex with men (MSM) were randomized to daily TDF/FTC vs. placebo in a multicenter, controlled trial with clinical sites in North America, Latin America, Thailand, and Africa.
-
-
